New locations of intravascular tissue factor

C. Reinhardt

doi:10.1055/s-0037-1616900

Hämostaseologie, Table of Contents

Hamostaseologie 2007; 27(01): 55-58
DOI: 10.1055/s-0037-1616900

Orginal Articles

Schattauer GmbH

New locations of intravascular tissue factor

IndicationsHinweise für neue Lokalisierungen des intravasalen Tissue-Fakors

C. Reinhardt

¹Vaskuläre Biologie und Hämostase, Institut für Klinische Chemie, Ludwig-Maximilians-Universität München, Germany

› Author Affiliations

Abstract

Summary

Tissue factor (TF) is the major initiator of blood coagulation, and a mediator of inflammation, angiogenesis, and carcinogenesis. According to recent evidence, preformed TF and inducible expression of the protein is observed in several blood components. TF is apparently constitutively expressed on circulating microparticles, and can be exposed within minutes on the cell membrane of activated eosinophils and platelets, and, potentially, on neutrophils. Expression in monocytes and neutrophils largely requires transcriptional activation of the TF gene. Eosinophils appear to harbour the highest concentration of preformed TF among all blood components under resting conditions. TF expression in eosinophil progenitor cells is substantially higher than in precursors of other granulocyte fractions. Eosinophil TF promotes transendothelial migration, which documents that presynthesized TF in blood supports functions apart from coagulation. It is still an open question how the intravascular TF is activated to trigger initiation of coagulation. TF activation in different blood components is likely to be differentially regulated according to the (patho)physiologic context.

Zusammenfassung

TF (tissue factor), ist das Starterprotein der Blutgerinnung. Außerdem ist TF bei Entzündungsprozessen, in der Gefäßbildung und bei der Entstehung von Tumoren von zentraler Bedeutung. Vor kurzem konnte TF in verschiedenen Blutbestandteilen nachgewiesen werden. TF wird auf zirkulierenden Mikropartikeln anscheinend konstitutiv exprimiert und kann innerhalb von Minuten auf der Zellmembran aktivierter Eosinophiler und Plättchen erscheinen. TF wird möglicherweise auch von Neutrophilen exprimiert. Die TFExpression in Monozyten und Neutrophilen erfordert im wesentlichen die Transkription des TF-Gens. Eosinophile beinhalten scheinbar die höchste Konzentration an bereits gebildetem TF unter allen nicht aktivierten Blutbestandteilen. Die TF-Expression in eosinophilen Vorläuferzellen ist beträchtlich höher als in Vorläuferzellen anderer Granulozytenfraktionen. TF auf Eosinophilen fördert die transendotheliale Migration. Dies belegt, dass vorgebildeter TF im Blut noch weitere Funktionen außer der Gerinnung unterstützt. Auf welche Weise der intravasale TF aktiviert wird, um den Gerinnungsstart auszulösen, ist unklar. Die Aktivierung von TF in verschiedenen Blutbestandteilen wird höchstwahrscheinlich differenziell, entsprechend dem jeweiligen (patho)physiologischen Kontext, reguliert.

Keywords

Tissue factor - coagulation - encryption - activation - platelets - monocytes - eosinophils - neutrophils - microparticles - intravascular - blood-borne - inflammation

Schlüsselwörter

Tissue-Faktor - Gewebethromboplastin - Blutgerinnung - Enkryptierung - Aktivierung - Plättchen - Monozyten - Eosinophile - Neutrophile - Mikropartikel - intravasal - Entzündung

Full Text

References

References
1 Abid Hussein MN, Meesters EW, Osmanovic N. et al. Antigenic characterization of endothelial cellderived microparticles and their detection ex vivo. J Thromb Haemost 2003; 1: 2434-43.
2 Aupeix K, Hugel B, Martin T. et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997; 99: 1546-54.
3 Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood 1997; 89: 3270-6.
4 Bach RR, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci USA 1990; 87: 6995-9.
5 Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 456-61.
6 Berckmans RJ, Neiuwland R, Boing AN. et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-46.
7 Camera M, Frigerio M, Toschi V. et al. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arterioscler Thromb Vasc Biol 2003; 23: 1690-6.
8 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of coagulation. Thromb Res 1996; 81: 1-41.
9 Cermak J, Key NS, Bach RR. et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
10 Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72: 128-33.
11 Del Conde I, Shrimpton CN, Thiagarajan P. et al. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-11.
12 Denis MM, Tolley ND, Bunting M. et al. Escaping the nuclear confines: signal-dependent premRNA splicing in anucleate platelets. Cell 2005; 122: 379-91.
13 Diamant M, Tushuizen ME, Sturk A. et al. Cellular microparticles: new players in the field of vascular disease?. Eur J Clin Invest 2004; 34: 392-401.
14 Drake TA, Cheng J, Chang A. et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-70.
15 Drake TA, Ruf W, Morrissey JH. et al. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989; 109: 389-95.
16 Engelmann B, Luther T, Muller I. Intravascular tissue factor pathway - a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost 2003; 89: 3-8.
17 Engelmann B. Initiation of coagulation by tissue factor carriers in blood. Blood Cells Mol Dis 2006; 36: 188-90.
18 Falati S, Gross P, Merrill-Skoloff G. et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-81.
19 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-98.
20 Giesen PL, Rauch U, Bohrmann B. et al. Bloodborne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
21 Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752-5.
22 Herbert JM, Savi P, Laplace MC. et al. IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 1992; 310: 31-3.
23 Hugel B, Martinez MC, Kunzelmann C. et al. Membrane microparticles: two sides of a coin. Physiology 2005; 20: 22-7.
24 Kaikita K, Ogawa H, Yasue H. et al. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol 1997; 17: 2232-7.
25 Landers SC, Gupta M, Lewis JC. Ultrastructural localization of tissue factor on monocyte-derived macrophages and macrophage foam cells associated with atherosclerotic lesions. Virchows Arch 1994; 425: 49-54.
26 Leatham EW, Bath PM, Tooze JA. et al. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-3.
27 Leon C, Alex M, Klocke A. et al. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004; 103: 594-600.
28 Lorenzet R, Niemetz J, Marcus AJ. et al. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J Clin Invest 1986; 78: 418-23.
29 Lupu C, Westmuckett AD, Peer G. et al. Tissue factor-dependent coagulation is preferentially upregulated within arterial branching areas in a ba- boon model of Escherichia coli sepsis. Am J Pathol 2005; 167: 1161-72.
30 Lyberg T, Prydz H. Phorbol esters induce synthesis of thromboplastin activity in human monocytes. Biochem J 1981; 194: 699-706.
31 Mackman N, Brand K, Edgington TS. Lipopolysaccharide- mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 1991; 174: 1517-26.
32 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3.
33 Mallat Z, Hugel B, Ohan J. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-53.
34 Maugeri N, Brambilla M, Camera M. et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 2006; 4: 1323-30.
35 Maynard JR, Dreyer BE, Stemerman MB. et al. Tissue factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 1977; 50: 387-96.
36 Maynard JR, Heckman CA, Pitlick FA. et al. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975; 55: 814.
37 Moosbauer C, Morgenstern E, Cuvelier SL. et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2006 in press.
38 Muller I, Klocke A, Alex M. et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476-8.
39 Niemetz J, Marcus AJ. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest 1974; 54: 1437-43.
40 Novotny WF, Girard TJ, Miletich JP. et al. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 1988; 72: 2020-5.
41 Oeth P, Parry GC, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and SP1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17: 365-74.
42 Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 605-17.
43 Osterud B, Rao LV, Olsen JO. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes. Thromb Haeost 2000; 83: 861-7.
44 Osterud B, Tindall A, Brox JH. et al. Thromboplastin content in the vessel walls of different arteries and organs of rabbits. Thromb Res 1986; 42: 323-9.
45 Osterud B. The role of platelets in decrypting monocyte tissue factor. Semin Hematol 2001; 38: 2-5.
46 Pinder PB, Hunt JA, Zacharski LR. In vitro stimulation of monocyte tissue factor activity by autologous platelets. Am J Hematol 1985; 19: 317-25.
47 Reininger AJ, Heijnen HF, Schumann H. et al. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006; 107: 3537-45.
48 Ritis K, Doumas M, Mastellos D. et al. A novel c5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 2006; 177: 4794-802.
49 Rivers RP, Hathaway WE, Weston WL. The endotoxin- induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-6.
50 Sabatier F, Roux V, Anfosso F. et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002; 99: 3962-70.
51 Satta N, Toti F, Bohbot A. et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994; 153: 3245-55.
52 Schwertz H, Tolley ND, Foulks JM. et al. Signaldependent splicing of tissue factor pre-mRNA modulated the thrombogenecity of human platelets. J Exp Med. 2006 in press.
53 Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78: 759-64.
54 Walsh JD, Geczy CL. Discordant expression of tissue factor antigen and procoagulant activity on human monocytes activated with LPS and low dose cycloheximide. Thromb Haemost 1991; 66: 552-8.
55 Wiedmer T, Sims PJ. Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood 1991; 78: 2880-6.
56 Wilcox JN, Smith KM, Schwartz SM. et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
57 Zillmann A, Luther T, Muller I. et al. Platelet-associated tissue factor contributes to the collagentriggered activation of blood coagulation. Biochem Biophys Res Commun 2001; 281: 603-9.